The intra- and interindividual heterogeneous <sup>64</sup>Cu-αCD19 uptake patterns of lymphoma lesions indicate variability in CD19 expression, suggesting the potential of CD19-immunoPET as a novel tool to guide CD19-directed therapies. Here, CD19 is linked to lymphoma.